Pulmatrix Stock Slides As Eos Merger Clock Starts To Matter For PULM Holders
Pulmatrix Inc shares slipped in thin early Nasdaq trading on Monday, with the stock again moving around the planned merger with Eos SENOLYTIX rather than a fresh drug-data catalyst. The stock was quoted at $1.37, down 1.44%, at 09:30:01 a.m. ET, with volume of about 1,010 shares against a three-month average of roughly 50,490. Investing.com listed the company’s market value at about $5 million and its 52-week range at $1.16 to $9.23. The Nasdaq Composite was down 0.15% in the same market snapshot, while the S&P 500 was off 0.09%.